ZC3H12A, which encodes the RNase monocyte chemotactic protein-induced protein 1 (MCPIP1), is up-regulated in psoriatic skin and reduced to normal levels after clinical treatments with anti-IL-17A/IL-17R neutralizing antibodies. In IL-17A-stimulated keratinocytes, MCPIP1 is rapidly increased at the transcript and protein levels. Also, IL-17A was found to be the main inducer of ZC3H12A expression in keratinocytes treated with supernatants derived from a Streptococcus pyogenes-activated psoriatic ex vivo model based on the co-culture of psoriatic cutaneous lymphocyte-associated antigen (CLA(+)) T cells and lesional epidermal cells. Moreover, MCPIP1 was aberrantly distributed in the suprabasal layers of psoriatic epidermis. In psoriatic samples, IL-17A-stimulated epidermal cell suspensions showed an increased MCPIP1 expression, especially in the mid-differentiated cellular compartment. The knockdown of ZC3H12A showed that this RNase participates in the regulation of the mRNAs present in suprabasal differentiated keratinocytes. Furthermore, JAK/STAT3 inhibition prevented the IL-17A-dependent induction of MCPIP1. In the mouse model of imiquimod-induced psoriasis, Zc3h12a expression was abrogated in Il17ra(-/-) mice. These results support the notion that IL-17A-mediated induction of MCPIP1 is involved in the regulation of local altered gene expression in suprabasal epidermal layers in psoriasis.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jid.2016.04.030 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Pulrodemstat, a selective inhibitor of KDM1A, suppresses head and neck squamous cell carcinoma growth by triggering apoptosis.
BMC Pharmacol Toxicol
November 2024
Department of Laboratory Medicine, Jiangnan University Medical Center (Wuxi No.2 People's Hospital), Wuxi, Jiangsu, 214000, China.
Background: Chemotherapy is often ineffective as a first-line treatment for head and neck squamous cell carcinoma (HNSCC), and a more precise and effective therapeutic option is urgently needed.
Methods: High-throughput screening of a histone demethylase inhibitor library was performed to identify potential drugs for treating HNSCC. The Cancer Genome Atlas (TCGA) and single-cell sequencing were used to evaluate the potential diagnostic value and expression distribution of candidate drug targets.
ARF alters PAF1 complex integrity to selectively repress oncogenic transcription programs upon p53 loss.
Mol Cell
December 2024
Department of Microbiology, The University of Texas Southwestern Medical Center, Dallas, TX, USA. Electronic address:
The polymerase associated factor 1 (PAF1) complex (PAF1c) promotes RNA polymerase II (RNA Pol II) transcription at the elongation step; however, how PAF1c transcription activity is selectively regulated during cell fate transitions remains poorly understood. Here, we reveal that the alternative reading frame (ARF) tumor suppressor operates at two levels to restrain PAF1c-dependent oncogenic transcriptional programs upon p53 loss in mouse cells. First, ARF assembles into homo-oligomers to bind the PAF1 subunit to promote PAF1c disassembly, consequently dampening PAF1c interaction with RNA Pol II and PAF1c-dependent transcription.
View Article and Find Full Text PDFLoss of miR-634 contributes to the formation FOXA1-positive triple negative breast cancer subtype.
Discov Oncol
October 2024
Department of Thyroid and Breast Surgery, The 904th Hospital of the Joint Logistics Support Force of PLA, 101 Xingyuan Road, Wuxi, 214044, Jiangsu, People's Republic of China.
Background: Triple-negative breast cancer (TNBC), the most aggressive subtype of breast cancer, lacks targeted therapies, posing a substantial challenge for treatment. Therefore, investigating its pathogenesis is a crucial research focus. FOXA1 and miR-634 are involved in tumorigenesis.
View Article and Find Full Text PDFCirc_0084653 promotes the tumor progression and immune escape in triple-negative breast cancer via the deubiquitination of MYC and upregulation of SOX5.
Int J Biol Macromol
September 2024
Department of Breast Oncology, Tianjin Medical University Cancer Institute & Hospital, Tianjin Medical University, Ministry of Education, Tianjin 300060, China; National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China; Key Laboratory of Cancer Prevention and Therapy, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin 300060, China. Electronic address:
Article Synopsis
- Circular RNAs (circRNAs) like circ_0084653, which arises from the COPS5 gene, are increasingly recognized for their role in triple-negative breast cancer (TNBC) and are shown to be upregulated in TNBC cells.* -
- Knockdown of COPS5 resulted in decreased cell proliferation, invasion, and other cancer traits, while circ_0084653 silence also inhibited TNBC progression, indicating a regulatory relationship between these molecules and cancer development.* -
- circ_0084653 enhances TNBC by deubiquitinating the MYC protein through USP36 recruitment and acting as a sponge for miR-1323, subsequently increasing the expression of the SOX5 gene, which
Identification of pancreatic adenocarcinoma immune subtype associated with tumor neoantigen from aberrant alternative splicing.
J Gastrointest Oncol
June 2024
Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Background: Pancreatic adenocarcinoma (PAAD) is referred to as an immunologically "cold" tumor that responds poorly to immunotherapy. A fundamental theory that explains the low immunogenicity of PAAD is the dramatically low tumor mutation burden (TMB) of PAAD tumors, which fails to induce sufficient immune response. Alternative splicing of pre-mRNA, which could alter the proteomic diversity of many cancers, has been reported to be involved in neoantigen production.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!